Company Announcements

Publication of Suppl.Prospcts

Source: RNS
RNS Number : 0682L
British Telecommunications PLC
03 September 2019
 

British Telecommunications public limited company

3 September 2019

Publication of Supplement updating Euro Medium Term Note Programme

The following Supplement has been approved by the Financial Conduct Authority and is available for viewing:

Supplement dated 3 September 2019 (the "Supplement") supplementing the Prospectus dated 16 July 2019 relating to the €20,000,000,000 Euro Medium Term Note Programme of British Telecommunications public limited company.

The Supplement incorporates by reference BT Group plc's Trading Update for First Quarter to 30 June 2019 and references certain recent developments.

To view the Supplement in full, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/0682L_1-2019-9-3.pdf

A copy of the Supplement will be submitted to the National Storage Mechanism and will be available shortly for inspection at: http://www.morningstar.co.uk/uk/NSM.

For further information, please contact:

BT Investor Relations

Tel: +44 20 7356 4909

E-mail: ir@bt.com

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Supplement you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained in the Supplement.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPUGUBABUPBGUW